Local anesthetic additives to increase stability and prevent organism growth

Techniques in Regional Anesthesia and Pain Management

Volumn 8, Issue 3, 2004, Pages 106-109

  Reichert, Marc G ^a   Butterworth, John ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BISULFITE; BUPIVACAINE; CHLOROPROCAINE; DRUG ADDITIVE; EDETIC ACID; ETIDOCAINE; GLUCOSE; HYDROCHLORIC ACID; LEVOBUPIVACAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; METHYL PARABEN; PRILOCAINE; PROCAINE; ROPIVACAINE; SODIUM CHLORIDE;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; DRUG DESIGN; DRUG MECHANISM; DRUG MIXTURE; DRUG STABILITY; ERYTHEMA; GROWTH INHIBITION; HUMAN; IMMUNOTOXICITY; LOCAL ANESTHESIA; MICROBIAL GROWTH; NEUROTOXICITY; NONHUMAN; PH; REVIEW; SHELF LIFE;

EID: 7044262194     PISSN: 1084208X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.trap.2004.03.003     Document Type: Article

References (28)

1. Local anesthetics. McEvoy G.K., Miller J., Snow E.K. AHFS Drug Information. 2003;3082-3094 American Society of Health-System Pharmacists, Inc, Bethesda, MD
2. Antimicrobial effectiveness testing: The United States Pharmacopeia, The National Formulary. 2004;2148-2150 United States Pharmacopeial Convention, Inc, Rockville, MD
3. Soni M.G., Taylor S.L., Greenberg N.A. Evaluation of the health aspects of methyl paraben A review of the published literature. Food Chem Toxicol. 40:2002;1335-1373
4. Package insert. Sensorcaine (bupivacaine). 2002;AstraZeneca, Wilmington, DE. March
5. Package insert. Nesacaine (chloroprocaine). 2000;AstraZeneca, Wilmington, DE. October
6. Package insert. Xylocaine (lidocaine). 2001;AstraZeneca, Wilmington, DE. September
7. Package insert. Polocaine (mepivacaine). 2000;AstraZeneca, Wilmington, DE. November
8. Sakuragi T., Ishino H., Dan K. Bactericidal activity of 0.5% bupivacaine with preservatives on microorganisms in the human skin flora. Reg Anesth. 22:1997;178-184
9. Sakuragi T., Ishino H., Dan K. Bactericidal activity of clinically used local anesthetics on Staphylococcus aureus. Reg Anesth. 21:1996;239-242
10. Hodgson P.S., Neal J.M., Pollock J.E. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg. 88:1999;797-809
11. Gurun M.S., Leinbach R., Moore L. Studies on the safety of glucose and paraben-containing neostigmine for intrathecal administration. Anesth Analg. 85:1997;317-323
12. Eisenach J.C., Hood D.D., Curry R. Phase I human safety assessment of intrathecal neostigmine containing methyl- and propylparabens. Anesth Analg. 85:1997;842-846
13. Eggleston S.T., Lush L.W. Understanding allergic reactions to local anesthetics. Ann Pharmacother. 30:1996;851-857
14. Kajimoto Y., Rosenberg M.E., Kytta J. Anaphylactoid skin reactions after intravenous regional anesthesia using 0.5% prilocaine with or without preservative A double-blind study. Acta Anaesthesiol Scand. 39:1995;782-784
15. Cartwright P.D., Fyhr P. The manufacture and storage of local anesthetics. Reg Anesth. 13:1988;1-12
16. Rowlingson J.C. Toxicity of local anesthetic additives. Reg Anesth. 18:1993;453-460
17. Smolinske S.C. Review of parenteral sulfite reactions. J Toxicol Clin Toxicol. 30:1992;597-606
18. Wang B.C., Hillman D.E., Spielholz N.I. Chronic neurological deficits and Nesacaine-CE An effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg. 63:1984;445-447
19. Gissen A.J., Datta S., Lambert D. The chloroprocaine controversy. I. A hypothesis to explain the neural complications of chloroprocaine epidural. Reg Anesth. 9:1984;124-134
20. Gissen A.J., Datta S., Lambert D. The chloroprocaine controversy. II. Is chloroprocaine neurotoxic? Reg Anesth. 9:1984;135-145
21. Taniguchi M., Bollen A.W., Drasner K. Sodium bisulfite Scapegoat for chloroprocaine neurotoxicity? Anesthesiology. 100:2004;85-91
22. 2 pretreatment; observation of spinal nerve root degeneration. Anesth Analg. 75:1992;895-899
23. Stevens R.A. Back pain following epidural anesthesia with 2-chloroprocaine. (editorial) Reg Anesth. 22:1997;299-301
24. Drolet P., Veillette Y. Back pain following epidural anesthesia with 2-chloroprocaine (EDTA-free) or lidocaine. Reg Anesth. 22:1997;303-307
25. Package insert. Naropin (ropivacaine). 2002;AstraZeneca, Wilmington, DE. July
26. Package insert. Chirocaine (levobupivacaine). 2000;Ben Venue Laboratories, Inc, Bedford, OH. September
27. DiFazio C.A., Carron H., Grosslight K.R. Comparison of pH-adjusted lidocaine solutions for epidural anesthesia. Anesth Analg. 65:1986;760-764
28. Steinbrook R.A., Hughes N., Fanciullo G. Effects of alkalinization of lidocaine on the pain of skin infiltration and intravenous catheterization. J Clin Anesth. 5:1993;456-458